Somatic Mutation Profiling and Associations With Prognosis and Trastuzumab Benefit in Early Breast Cancer

Lignende værker

• Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer
  af: Sonnenblick, Amir, et al.
  Udgivet: (2015)
• Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX)
  af: Joensuu, Heikki, et al.
  Udgivet: (2014)
• Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Fin-her phase III randomized trial
  af: Sonnenblick, Amir, et al.
  Udgivet: (2015)
• Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays
  af: Jose, Vinu, et al.
  Udgivet: (2018)
• Deep learning identifies morphological features in breast cancer predictive of cancer ERBB2 status and trastuzumab treatment efficacy
  af: Bychkov, Dmitrii, et al.
  Udgivet: (2021)